Awarded

RMH - CAR-T Treatment

Request tender documents

Save your time. You just request and we will send you the documents

Descriptions

CAR-T treatment called Obecel developed to treat relapsed or refractory B-cell precursor acute lymphoblastic leukaemia (r/r B-ALL) which has recently become available to patients. The decision which treatment is most suitable applicable to a specific age group is a clinical one that would be decided by a Multi-Disciplinary Team (MDT). The product should meet strict NHS England standards for cryogenic storage and handling and RMH has such credentials.

Timeline

Published Date :

24th Oct 2025 10 days ago

Deadline :

N/A

Contract Start :

N/A

Contract End :

N/A

Tender Regions

North West South West North East East of England Yorkshire and The Humber South East East Midlands West Midlands Ireland Wales Scotland Northern Ireland London

CPV Codes

33600000 - Pharmaceutical products

Keywords

medicinal drugs

prescription medicines

generic pharmaceuticals

active pharmaceutical ingredients

pharmaceutical compounds

Tender Lot Details

2 Tender Lots

Let’s Get you Started ✍

Get to see all tender details more briefly

Already have an account ? Log in

Workflows

Status :

Awarded

Procedure :

N/A

Suitable for SME :

Yes

Nationwide :

Assign to :

Tender Progress :

Details

Notice Type :

Tender

Tender Identifier :

IT-378-246-T: 2024 - 001

Tenderbase ID :

310724019

Low Value :

£100K

High Value :

£1000K

Buyer Information

Name :

The Royal Marsden NHS Foundation Trust

Address :

Liverpool Merseyside , Merseyside , L13 0BQ

Website :

N/A

Procurement contact

Name :

Tina Smith

Phone :

0151 252 3243

Email :

tina.smith@shared-ed.ac.uk

Possible Competitors

1 Possible Competitors